Geller Advisors LLC Dexcom Inc Transaction History

Geller Advisors LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$110.31 - $140.45 $8,052 - $10,252	73 Added 2.7%	2,773 $314,000
Q1 2024 May 14, 2024	SELL	$114.22 - $140.1 $6,853 - $8,406	-60 Reduced 2.17%	2,700 $374,000
Q4 2023 Feb 14, 2024	BUY	$75.49 - $124.16 $19,551 - $32,157	259 Added 10.36%	2,760 $342,000
Q3 2023 Nov 13, 2023	SELL	$86.06 - $137.93 $1,721 - $2,758	-20 Reduced 0.79%	2,501 $233,000
Q2 2023 Aug 09, 2023	BUY	$112.47 - $130.98 $283,536 - $330,200	2,521 New	2,521 $323,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Geller Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Geller Advisors LLC with notifications on news.